Effect of benfotiamine on hepatic tissue levels of free calcium, copper, iron and zinc during CCl4-induced hepatotoxicity in rats

  • Tavga Ahmed Aziz Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Sulaimania, Iraq
Keywords: benfotiamine, CCl4, hepatotoxicity, calcium, trace elements


Background and Objectives: Toxic injury occurs in the liver more often than other organ, this can be attributed to the fact that virtually all ingested substances that are absorbed are first presented to the liver & that the liver is responsible for the metabolism and elimination of many substances. Carbon tetrachloride (CCl4) is very well known to cause hepatotoxicity that may be associated with impaired calcium and trace element homeostasis. This study was designed to evaluate the protective effect of benfotiamine against CCl4-induced disturbances in calcium, iron, copper and zinc homeostasis in liver tissue of rats.

Methods: Liver tissue homogenate from normal controls, CCl4-treated and benfotiamine (70 mg/kg) pre-treated before induction of hepatic damage with CCl4 in rats were obtained, and processed for estimation of levels of free forms of calcium, iron, copper and zinc using atomic absorption spectrophotometry.

Results: Analysis of data revealed significant elevation in calcium, iron and copper levels in hepatic tissue due to exposure to CCl4 compared to controls, while zinc levels not significantly affected. Pretreatment with benfotiamine results in significant decrease in calcium, iron and copper levels compared to non-treated group, while zinc levels found to be significantly elevated.

Conclusions: Benfotiamine has a protective effect against CCl4-induced hepatic tissue damage which may be, in part, attributed to restoration of calcium and other trace elements homeostasis.


Hartmut J. Toxic responses of the liver. In: Casarett and Doull's Toxicology: The basic science of poisons. 7th edition, 2008:557-582.

Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22:287-305.

John MC. Mechanistic Classification of Liver Injury. Toxicol Pathol 2005; 33:6-8.

Lemaster JJ. Mechanisms of hepatic toxicity. Necraptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis. Am J Physiol 1999; 276: G1-G6.

Berridge MJ, Bootman MD, Lipp P. Calcium: A life and death signal. Nature 1998; 395:645-648.

Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33(2):105-136.

Johnston DE, Kroening C. Mechanism of early CCl4-toxicity in cultured rat hepatocytes. Pharmacol Toxicol 1998; 39:231-239.

Dani C, Pasquali MA, Oliveira MR, Umezu FM, et al. Protective Effects of Purple Grape Juice on Carbon Tetrachloride-Induced Oxidative Stress in Brains of Adult Wistar Rats. J Med Food 2008; 11(1):55-61.

Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd ed. Clarendon, Oxford, 1999.

Tapiaro H, Towensend DM, Tevv KD. Trace elements in human physiology and pathology. Biomed pharmacother 2003; 57(9):386-398.

Marchetti V, Menghini R, Rizza S, Vivanti A, et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes, 2006; 55: 2231-2237.

Wu S, Ren J. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett 2006; 394: 158-162.

Gadau S, Emanueli C, Van Linthout S, Graiani G, et al.. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia 2006; 49: 405-420.

Ceylan-Isik AF, Wu S, Li Q, Li SY, Ren J. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol 2006; 100: 150-156.

Bruce AM, Milnen A, Peter JW. Introduction to atomic spectrophotometry. Clinical Lab Methods. The C.V. Mosby Company, Saint Louis. 1984, 78-80.

Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaie A. Pesticides and oxidative stress. Med Sci Monit 2004; 10:141–147.

Brette F, Leroy J, Le Guennec JY, Salle L. Ca2+ currents in cardiac myocytes: old story, new insights. Prog Biophys Mol Biol 2006; 91:1-82.

Xiao YH, Liu DW, Li Q. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. J Gastroenterol 2005; 11:1515-20.

Nakamura T, Arii S, Monden K, Furutani M, Takeda Y, Imamura M, et al. Expression of the Na+/Ca2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Proc Natl Acad Sci USA 1998; 95:5389-94.

Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in liver fibrosis. Front Biosci 2002; 7:793-807.

Elisabetta M, Gioacchino S. Copper-induced changes of non-protein thiols and antioxidant enzymes in the marine microalga Phaeodactylum tricornutum. Plant Sci 2004; 167: 289-296.

Liu J, Goyer RA, Waalker MP. Toxic Effect of Metals. In Casarett and Doull's toxicology: The basic science of poisons. 7th edition, 2008, 931-979.

Knauer K, Behra R, Sigg L. Effects of free Cu2+ and Zn2+ ions on growth and metal accumulation in fresh-water algae. Environ Toxicol Chem 1997; 16(2):220-229.

Deitmer JW, Ivens I, Pernberg J. Changes in voltage-dependent calcium currents during the cell cycle of the ciliate Stylonychia. Exp Cell Res 1986; 162:549-54.

Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000: a historical look to the future. Ann N Y Acad Sci 2000; 899; 136–147.

Arezzini B, Lunghi B, Lungarella G, Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int J Biochem Cell Biol 2003; 35:486-495.

Sidhu P, Garg ML, Morgenstern P, Vogt J, et al. Role of zinc in regulating the levels of hepatic elements following nickel toxicity in rats. Biol Trace Elem Res 2004; 102:161–172.

Arezzini B, Lunghi B, Lungarella G, Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int J Biochem Cell Biol 2003; 35:486–495.

Hammes H, Du X, Edelstein D, Taguchi T, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Med 2003; 9(3):294-300.

Stirban A, Negrean M, Stratmann B, Gawlowski T, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006; 29:2064–2071.

Aziz TA, Ahmed ZA, Juma'a KM, Abdulrazzaq MH, Hussain SA. Study of the protective effects of benfotiamine against CCl4-induced hepatotoxicity in rats. Iraqi J Pham Sci 2009; 18:47-53.

Stracke H, Hammes HP, Werkmann D, Mavrakis K, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diab 2001; 109:330-336.

Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans 2003; 31:1423-1425.

Balakumar P, Ramica Sharma R, Singh M. Benfotiamine attenuates nicotine, uric acid-induced vascular endothelial dysfunction in the rat. Pharmacological Research 2008; 101: 210-214.

Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003; 52:2110-212

How to Cite
Aziz, T. (2018). Effect of benfotiamine on hepatic tissue levels of free calcium, copper, iron and zinc during CCl4-induced hepatotoxicity in rats. Zanco Journal of Medical Sciences (Zanco J Med Sci), 15(2), 10-14. Retrieved from https://zjms.hmu.edu.krd/index.php/zjms/article/view/412
Original Articles